Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Camphausen K, Menard C. Angiogenesis inhibitors and radiotherapy of primary tumours. Expert Opin Biol Ther. 2002 Jun;2(5):477-81. doi: 10.1517/14712598.2.5.477. Review. PubMed PMID: 12079484.
Camphausen K, Moses MA, Ménard C, Sproull M, Beecken WD, Folkman J, O'Reilly MS. Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 2003 Apr 15;63(8):1990-3. PubMed PMID: 12702593.
Camphausen K, Sproull M, Tantama S, Sankineni S, Scott T, Ménard C, Coleman CN, Brechbiel MW. Evaluation of copper chelation agents as anti-angiogenic therapy. Bioorg Med Chem. 2003 Sep 15;11(19):4287-93. doi: 10.1016/s0968-0896(03)00401-2. PubMed PMID: 12951159.
Ménard C, Camphausen K, Muanza T, Sears-Crouse N, Smith S, Ben-Josef E, Coleman CN. Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results. Semin Oncol. 2003 Dec;30(6 Suppl 18):63-7. doi: 10.1053/j.seminoncol.2003.11.016. PubMed PMID: 14727242.
Dertinger SD, Camphausen K, Macgregor JT, Bishop ME, Torous DK, Avlasevich S, Cairns S, Tometsko CR, Menard C, Muanza T, Chen Y, Miller RK, Cederbrant K, Sandelin K, Pontén I, Bolcsfoldi G. Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood. Environ Mol Mutagen. 2004;44(5):427-35. doi: 10.1002/em.20075. PubMed PMID: 15517570.
Chan LW, Moses MA, Goley E, Sproull M, Muanza T, Coleman CN, Figg WD, Albert PS, Ménard C, Camphausen K. Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol. 2004 Feb 1;22(3):499-506. doi: 10.1200/JCO.2004.07.022. PubMed PMID: 14752073.
Citrin D, Scott T, Sproull M, Menard C, Tofilon PJ, Camphausen K. In vivo tumor imaging using a near-infrared-labeled endostatin molecule. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):536-41. doi: 10.1016/j.ijrobp.2003.09.068. PubMed PMID: 14751525.
Camphausen K, Ménard C, Sproull M, Goley E, Basu S, Coleman CN. Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1536-9. doi: 10.1016/j.ijrobp.2003.09.011. PubMed PMID: 15050334.
Citrin D, Lee AK, Scott T, Sproull M, Ménard C, Tofilon PJ, Camphausen K. In vivo tumor imaging in mice with near-infrared labeled endostatin. Mol Cancer Ther. 2004 Apr;3(4):481-8. PubMed PMID: 15078992.
Goley EM, Anderson SJ, Ménard C, Chuang E, Lü X, Tofilon PJ, Camphausen K. Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors. BMC Cancer. 2004 May 19;4:20. doi: 10.1186/1471-2407-4-20. PubMed PMID: 15151703; PubMed Central PMCID: PMC441381.
Ménard C, Susil RC, Choyke P, Gustafson GS, Kammerer W, Ning H, Miller RW, Ullman KL, Sears Crouse N, Smith S, Lessard E, Pouliot J, Wright V, McVeigh E, Coleman CN, Camphausen K. MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1414-23. doi: 10.1016/j.ijrobp.2004.01.016. PubMed PMID: 15275727; PubMed Central PMCID: PMC2396328.
Susil RC, Camphausen K, Choyke P, McVeigh ER, Gustafson GS, Ning H, Miller RW, Atalar E, Coleman CN, Ménard C. System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner. Magn Reson Med. 2004 Sep;52(3):683-7. doi: 10.1002/mrm.20138. PubMed PMID: 15334592; PubMed Central PMCID: PMC2396258.
Ménard C, Susil RC, Choyke P, Coleman J, Grubb R, Gharib A, Krieger A, Guion P, Thomasson D, Ullman K, Gupta S, Espina V, Liotta L, Petricoin E, Fitchtinger G, Whitcomb LL, Atalar E, Coleman CN, Camphausen K. An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement. Mol Imaging. 2005 Jan-Mar;4(1):63-6. doi: 10.1162/15353500200504181. PubMed PMID: 15967127; PubMed Central PMCID: PMC3299492.
Krieger A, Susil RC, Ménard C, Coleman JA, Fichtinger G, Atalar E, Whitcomb LL. Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng. 2005 Feb;52(2):306-13. doi: 10.1109/TBME.2004.840497. PubMed PMID: 15709668; PubMed Central PMCID: PMC3299496.
Citrin D, Ning H, Guion P, Li G, Susil RC, Miller RW, Lessard E, Pouliot J, Huchen X, Capala J, Coleman CN, Camphausen K, Ménard C. Inverse treatment planning based on MRI for HDR prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1267-75. doi: 10.1016/j.ijrobp.2004.11.024. PubMed PMID: 15752909.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W. Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res. 2005 May 1;11(9):3353-62. doi: 10.1158/1078-0432.CCR-04-2062. PubMed PMID: 15867235.
Atalar E, Ménard C. MR-guided interventions for prostate cancer. Magn Reson Imaging Clin N Am. 2005 Aug;13(3):491-504. doi: 10.1016/j.mric.2005.04.012. Review. PubMed PMID: 16084415.
Muanza TM, Albert PS, Smith S, Godette D, Crouse NS, Cooley-Zgela T, Sciuto L, Camphausen K, Coleman CN, Ménard C. Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1316-21. doi: 10.1016/j.ijrobp.2004.12.083. PubMed PMID: 16029787.
Citrin D, Ménard C, Camphausen K. Combining radiotherapy and angiogenesis inhibitors: clinical trial design. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):15-25. doi: 10.1016/j.ijrobp.2005.03.065. PubMed PMID: 16377411.
Susil RC, Ménard C, Krieger A, Coleman JA, Camphausen K, Choyke P, Fichtinger G, Whitcomb LL, Coleman CN, Atalar E. Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. J Urol. 2006 Jan;175(1):113-20. doi: 10.1016/S0022-5347(05)00065-0. PubMed PMID: 16406885; PubMed Central PMCID: PMC3299542.
Ménard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, Liotta L, Camphausen K. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res. 2006 Feb 1;66(3):1844-50. doi: 10.1158/0008-5472.CAN-05-3466. PubMed PMID: 16452246.
Ullman KL, Ning H, Susil RC, Ayele A, Jocelyn L, Havelos J, Guion P, Xie H, Li G, Arora BC, Cannon A, Miller RW, Coleman CN, Camphausen K, Ménard C. Intra- and inter-radiation therapist reproducibility of daily isocenter verification using prostatic fiducial markers. Radiat Oncol. 2006 Feb 28;1:2. doi: 10.1186/1748-717X-1-2. PubMed PMID: 16722575; PubMed Central PMCID: PMC1436003.
Singh AK, Ménard C, Guion P, Simone NL, Smith S, Crouse NS, Godette DJ, Cooley-Zgela T, Sciuto LC, Coleman J, Pinto P, Albert PS, Camphausen K, Coleman CN. Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1008-13. doi: 10.1016/j.ijrobp.2006.02.030. Epub 2006 May 26. PubMed PMID: 16730138.
Singh AK, Guion P, Susil RC, Citrin DE, Ning H, Miller RW, Ullman K, Smith S, Crouse NS, Godette DJ, Stall BR, Coleman CN, Camphausen K, Ménard C. Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost. Radiat Oncol. 2006 Aug 16;1:28. doi: 10.1186/1748-717X-1-28. PubMed PMID: 16914054; PubMed Central PMCID: PMC1564026.
Koh ES, Millar BA, Ménard C, Michaels H, Heydarian M, Ladak S, McKinnon S, Rutka JA, Guha A, Pond GR, Laperriere NJ. Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital. Cancer. 2007 Mar 15;109(6):1203-10. doi: 10.1002/cncr.22499. PubMed PMID: 17318817.
Milosevic M, Chung P, Parker C, Bristow R, Toi A, Panzarella T, Warde P, Catton C, Menard C, Bayley A, Gospodarowicz M, Hill R. Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response. Cancer Res. 2007 Jul 1;67(13):6022-5. doi: 10.1158/0008-5472.CAN-07-0561. PubMed PMID: 17616657.
Hensel JM, Ménard C, Chung PW, Milosevic MF, Kirilova A, Moseley JL, Haider MA, Brock KK. Development of multiorgan finite element-based prostate deformation model enabling registration of endorectal coil magnetic resonance imaging for radiotherapy planning. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1522-8. doi: 10.1016/j.ijrobp.2007.04.004. PubMed PMID: 17674983.
Martin JM, Rosewall T, Bayley A, Bristow R, Chung P, Crook J, Gospodarowicz M, McLean M, Ménard C, Milosevic M, Warde P, Catton C. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1084-9. doi: 10.1016/j.ijrobp.2007.04.049. Epub 2007 Jul 2. PubMed PMID: 17606331.
Wiltshire KL, Brock KK, Haider MA, Zwahlen D, Kong V, Chan E, Moseley J, Bayley A, Catton C, Chung PW, Gospodarowicz M, Milosevic M, Kneebone A, Warde P, Ménard C. Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1090-9. doi: 10.1016/j.ijrobp.2007.04.068. PubMed PMID: 17967303.
Koh ES, Nichol A, Millar BA, Ménard C, Pond G, Laperriere NJ. Role of fractionated external beam radiotherapy in hemangioblastoma of the central nervous system. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1521-6. doi: 10.1016/j.ijrobp.2007.05.025. Epub 2007 Sep 14. PubMed PMID: 17869023.
Singh AK, Krieger A, Lattouf JB, Guion P, Grubb RL 3rd, Albert PS, Metzger G, Ullman K, Smith S, Fichtinger G, Ocak I, Choyke P, Ménard C, Coleman J. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. BJU Int. 2008 Jan;101(2):181-5. doi: 10.1111/j.1464-410X.2007.07219.x. Epub 2007 Oct 8. PubMed PMID: 17922874.
Simone NL, Ménard C, Soule BP, Albert PS, Guion P, Smith S, Godette D, Crouse NS, Sciuto LC, Cooley-Zgela T, Camphausen K, Coleman CN, Singh AK. Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):90-5. doi: 10.1016/j.ijrobp.2007.05.057. Epub 2007 Sep 12. PubMed PMID: 17855015; PubMed Central PMCID: PMC2267374.
Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30. doi: 10.1016/j.ijrobp.2007.06.029. Epub 2007 Sep 19. PubMed PMID: 17881141.
Prakash V, Stainsby JA, Satkunasingham J, Craig T, Catton C, Chan P, Dawson L, Hensel J, Jaffray D, Milosevic M, Nichol A, Sussman MS, Lockwood G, Ménard C. Validation of supervised automated algorithm for fast quantitative evaluation of organ motion on magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1253-60. doi: 10.1016/j.ijrobp.2007.11.021. Epub 2008 Jan 22. PubMed PMID: 18207656.
Brock KK, Nichol AM, Ménard C, Moseley JL, Warde PR, Catton CN, Jaffray DA. Accuracy and sensitivity of finite element model-based deformable registration of the prostate. Med Phys. 2008 Sep;35(9):4019-25. doi: 10.1118/1.2965263. PubMed PMID: 18841853.
Christensen E, Evans KR, Ménard C, Pintilie M, Bristow RG. Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials. Cancer Metastasis Rev. 2008 Sep;27(3):375-85. doi: 10.1007/s10555-008-9139-6. Review. PubMed PMID: 18427732.
Vachhrajani S, Fawaz C, Mathieu D, Ménard C, Cusimano MD, Gentili F, Hodaie M, Kenny B, Kulkarni AV, Laperriere N, Schwartz M, Tsao M, Bernstein M. Complications of Gamma Knife surgery: an early report from 2 Canadian centers. J Neurosurg. 2008 Dec;109 Suppl:2-7. doi: 10.3171/JNS/2008/109/12/S2. PubMed PMID: 19123881.
Rosewall T, Kong V, Vesprini D, Catton C, Chung P, Ménard C, Bayley A. Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses. Radiother Oncol. 2009 Mar;90(3):325-30. doi: 10.1016/j.radonc.2008.11.015. Epub 2008 Dec 31. PubMed PMID: 19121547.
Kelloff GJ, Choyke P, Coffey DS. Challenges in clinical prostate cancer: role of imaging. AJR Am J Roentgenol. 2009 Jun;192(6):1455-70. doi: 10.2214/AJR.09.2579. PubMed PMID: 19457806; PubMed Central PMCID: PMC2893141.
Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O'Meara E, Rosenthal SA, Ritter M, Seider M. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):383-7. doi: 10.1016/j.ijrobp.2008.08.002. Epub 2008 Oct 22. PubMed PMID: 18947938; PubMed Central PMCID: PMC2905150.
Sahgal A, Ma L, Chang E, Shiu A, Larson DA, Laperriere N, Yin FF, Tsao M, Menard C, Basran P, Létourneau D, Heydarian M, Beachey D, Shukla V, Cusimano M, Hodaie M, Zadeh G, Bernstein M, Schwartz M. Advances in technology for intracranial stereotactic radiosurgery. Technol Cancer Res Treat. 2009 Aug;8(4):271-80. doi: 10.1177/153303460900800404. Review. PubMed PMID: 19645520.
Christensen E, Pintilie M, Evans KR, Lenarduzzi M, Ménard C, Catton CN, Diamandis EP, Bristow RG. Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity. Clin Cancer Res. 2009 Sep 1;15(17):5576-83. doi: 10.1158/1078-0432.CCR-09-0245. Epub 2009 Aug 25. PubMed PMID: 19706801.
Chopra S, Foltz WD, Milosevic MF, Toi A, Bristow RG, Ménard C, Haider MA. Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancer. Int J Radiat Biol. 2009 Sep;85(9):805-13. doi: 10.1080/09553000903043059. PubMed PMID: 19728195.
Vanderspek L, Bauman G, Wang JZ, Yartsev S, Ménard C, Cho YB, Mundt AJ, Lawson JD, Murphy KT. Dosimetric comparison of intensity-modulated radiosurgery and helical tomotherapy for the treatment of multiple intracranial metastases. Technol Cancer Res Treat. 2009 Oct;8(5):361-7. doi: 10.1177/153303460900800506. PubMed PMID: 19754212.
Finelli A, Punnen S, Rosewall T, Catton C, Fleshner N, Jewett M, Trachtenberg J, Menard C. Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapy. J Urol. 2009 Nov;182(5):2280-4. doi: 10.1016/j.juro.2009.07.037. Epub 2009 Sep 16. PubMed PMID: 19762047.
Martin JM, Bayley A, Bristow R, Chung P, Gospodarowicz M, Menard C, Milosevic M, Rosewall T, Warde PR, Catton CN. Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol. 2009 Nov 3;4:50. doi: 10.1186/1748-717X-4-50. PubMed PMID: 19887007; PubMed Central PMCID: PMC2777178.
Dawson LA, Ménard C. Imaging in radiation oncology: a perspective. Oncologist. 2010;15(4):338-49. doi: 10.1634/theoncologist.2009-S106. Review. PubMed PMID: 20413639; PubMed Central PMCID: PMC3227970.
Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti RK, Zietman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):361-8. doi: 10.1016/j.ijrobp.2009.02.006. Epub 2009 Apr 23. PubMed PMID: 19394158; PubMed Central PMCID: PMC2847420.
Sia M, Rodrigues G, Menard C, Bayley A, Bristow R, Chung P, Gospodarowicz M, Milosevic M, Warde P, Catton C. Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer. Can Urol Assoc J. 2010 Apr;4(2):105-11. doi: 10.5489/cuaj.801. PubMed PMID: 20368892; PubMed Central PMCID: PMC2845745.
MacFadden D, Zhang B, Brock KK, Hodaie M, Laperriere N, Schwartz M, Tsao M, Stainsby J, Lockwood G, Mikulis D, Ménard C. Clinical evaluation of stereotactic target localization using 3-Tesla MRI for radiosurgery planning. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1472-9. doi: 10.1016/j.ijrobp.2009.03.020. Epub 2009 Jun 8. PubMed PMID: 19515512.
What would you like to do?